Tag: 3Spine

First US surgeries performed in BalancedBack total joint replacement IDE trial

3Spine has announced completion of the first series of US surgeries in the BalancedBack total joint replacement investigational device exemption (IDE) pivotal clinical trial. All...

3Spine granted investigational device exemption approval

3Spine has announced US Food and Drug Administration (FDA) investigational device exemption (IDE) approval for a US pivotal clinical trial for their MOTUS spinal...

3Spine appoints Pierce Nunley to medical advisory board

3Spine has announced the appointment of Pierce Nunley, director of the Spine Institute of Louisiana (Shreveport, USA), to its medical advisory board. The appointment was...

3Spine raises US$33 million in Series C funding round

3Spine has raised US$33 million in an oversubscribed Series C private offering, the proceeds of which will be used to fund a Phase 2...